These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 25452197

  • 1. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor M.
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [Abstract] [Full Text] [Related]

  • 2. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S, Ormiston J, Bergmann MW, Sievert H, Schwindt A, Werner N, Vogel B, Colombo A.
    EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
    [Abstract] [Full Text] [Related]

  • 3. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [Abstract] [Full Text] [Related]

  • 4. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 5. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, ICV-GVM la Roseraie.
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.
    Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V.
    Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649
    [Abstract] [Full Text] [Related]

  • 8. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
    Weber MA, Kirtane AJ, Weir MR, Radhakrishnan J, Das T, Berk M, Mendelsohn F, Bouchard A, Larrain G, Haase M, Diaz-Cartelle J, Leon MB.
    JACC Cardiovasc Interv; 2020 Feb 24; 13(4):461-470. PubMed ID: 32081240
    [Abstract] [Full Text] [Related]

  • 9. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 10. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2013 Aug 12; 36(4):987-91. PubMed ID: 23771326
    [Abstract] [Full Text] [Related]

  • 11. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ.
    Atherosclerosis; 2017 Jul 12; 262():94-100. PubMed ID: 28531827
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study.
    Daemen J, Mahfoud F, Kuck KH, Andersson B, Böhm M, Graf T, Sievert H, Kahlert P, Iyer M, Zeller T.
    J Hypertens; 2019 Sep 12; 37(9):1906-1912. PubMed ID: 31045964
    [Abstract] [Full Text] [Related]

  • 13. Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes.
    Al Ghorani H, Kulenthiran S, Lauder L, Recktenwald MJM, Dederer J, Kunz M, Götzinger F, Ewen S, Ukena C, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2024 Oct 12; 113(10):1384-1392. PubMed ID: 38451261
    [Abstract] [Full Text] [Related]

  • 14. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb 12; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 15. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.
    Eur Heart J; 2013 Jul 12; 34(28):2114-21. PubMed ID: 23786861
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.
    Al Raisi SI, Pouliopoulos J, Qian P, King P, Byth K, Barry MT, Swinnen J, Thiagalingam A, Kovoor P.
    Catheter Cardiovasc Interv; 2019 Feb 15; 93(3):E105-E111. PubMed ID: 30549404
    [Abstract] [Full Text] [Related]

  • 17. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program.
    Can J Cardiol; 2014 Jan 15; 30(1):16-21. PubMed ID: 24269056
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL, SYMPLICITY HTN-3 Steering Committee Investigators.
    Lancet; 2022 Oct 22; 400(10361):1405-1416. PubMed ID: 36130612
    [Abstract] [Full Text] [Related]

  • 19. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 20. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H, Mathiassen ON, Kaltoft A, Pedersen EB, Christensen KL, Buus NH, Lederballe O, Lassen JF, Bøtker HE, Thuesen L.
    Dan Med J; 2012 Jun 10; 59(6):A4439. PubMed ID: 22677237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.